CN208436254U - A kind of interventional therapy conduit hemostasis device - Google Patents

A kind of interventional therapy conduit hemostasis device Download PDF

Info

Publication number
CN208436254U
CN208436254U CN201820386154.2U CN201820386154U CN208436254U CN 208436254 U CN208436254 U CN 208436254U CN 201820386154 U CN201820386154 U CN 201820386154U CN 208436254 U CN208436254 U CN 208436254U
Authority
CN
China
Prior art keywords
conduit
supervisor
interventional therapy
utility
hemostasis device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201820386154.2U
Other languages
Chinese (zh)
Inventor
金永志
李梦帆
黄荣
黄毅
曾光
陈智彬
胡俊晟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI PUTUO DISTRICT CENTRAL HOSPITAL
Original Assignee
SHANGHAI PUTUO DISTRICT CENTRAL HOSPITAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI PUTUO DISTRICT CENTRAL HOSPITAL filed Critical SHANGHAI PUTUO DISTRICT CENTRAL HOSPITAL
Priority to CN201820386154.2U priority Critical patent/CN208436254U/en
Application granted granted Critical
Publication of CN208436254U publication Critical patent/CN208436254U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The utility model discloses a kind of interventional therapy conduit hemostasis devices, which includes: body assembly and extension component, which includes: shell;It is arranged in the intracorporal supervisor of shell;The pipe joint element for connecting conduit of supervisor front end is set;The rear cover of supervisor rear end is set;And the haemostatic valve of rear cover inner wall is set;The extension component includes: it is connected to the side pipe of supervisor, and, the three-way cock of side pipe end is set.Device manufacturing provided by the utility model is at low cost, uses simplicity, tissue blood vessel damage can effectively be mitigated, reduce patient suffering, leakage blood can be effectively prevent when carrying out seal wire operation, also smaller size of conduit can be placed in by utility model device, more convenient for medical worker operates and treats, applicable scene is greatly improved, and clinical application is very extensive.

Description

A kind of interventional therapy conduit hemostasis device
Technical field
The utility model relates to a kind of medical instruments, are placed in endarterial conduit for connecting more particularly, to one kind Device, can effectively preventing blood outflow, while carry out the drug injection in conduit and follow-up seal wire, i.e., so that conduit has The function of vagina vasorum, plays respective action during surgery.
Background technique
New discipline, surgical procedure rely on the consumptive materials such as various seal wires, conduit, vagina vasorum in recent years for blood vessel intervening acts.
Clinically in the diseases such as vascular interventional treatment arterial occlusion or stenotic lesion, as femoral artery stenosis, common iliac artery are narrow A series of arteriarctias such as narrow, renal artery stenosis or the disease of occlusion, the method generallyd use are to be placed in vagina vasorum in the blood vessels Lesion vessels are reached using seal wire cooperation conduit afterwards, in conduit expert's angiography, recycle seal wire by lesion vessels, at this time The case where being commonly encountered blood back when catheter opening blood pressure is high, a large amount of blood are leaked out from catheter tip.
Also often the corresponding vagina vasorum of replacement is taken to reach anti-return blood and further hand according to different blood vessels is out of shape at present The purpose of art operation, such as: arteria renalis sheath is exactly one kind of this kind of device, can be effective after arteria renalis sheath is placed in the arteria renalis Anti- return blood, and can be in the further surgical procedure of intrathecal row, but the such specific blood vessels sheath price of arteria renalis sheath is higher, and needs to replace Vagina vasorum increases the operation of more replacement conduits, vagina vasorum in blood vessel intervention operation, increases operating time and operation Risk also increases the financial burden of patient.
Utility model content
The purpose of the utility model is to provide a kind of conduit hemostasis devices of connecting conduit end, can effectively prevent conduit Follow up seal wire or conduit while the blood back of end, also can be by present apparatus side pipe in intravascular carry out drug injection, so that conduit Have the function of part vagina vasorum, play anti-return blood in intervention operation, reduce the number of replacement vagina vasorum, improves operation peace Overall coefficient reduces operation consumptive material, reduces the effect of patient economy burden.
A kind of in order to achieve the above object, the utility model provides interventional therapy conduit hemostasis device, which includes: Body assembly and extension component, the body assembly includes:
Shell;
It is arranged in the intracorporal supervisor of shell;
The pipe joint element of supervisor front end is set;
The rear cover of supervisor rear end is set;And
The haemostatic valve of rear cover inner wall is set;
The extension component includes: it is connected to the side pipe of supervisor, and, the three-way cock of side pipe end is set, blood is used for Injection drug and flushing haemostatic valve in pipe.
Preferably, the pipe joint element selection conduit connects knob, conduit connection knob is internally threaded, can lead to The mode screwed is crossed to be fixedly connected with a variety of conduits.
Preferably, the haemostatic valve is made of several elastics;
Preferably, the haemostatic valve is made of 3 elastics for being embedded side by side in rear cover inner wall, supervisor can be blocked. More preferably, 3 elastics are equidistant is embedded in rear cover, when being inserted into seal wire or conduit, can effectively stop the leakage of blood.
Preferably, the elastic column section is round or similar round.
Preferably, the rear cover is sheath lid, and it is hollow, inside set haemostatic valve.
Herein, " front end " refers to one end when haemostatic valve is placed on conduit close to conduit, and " rear end " refers to hemostasis Far from one end of conduit when valve is placed on conduit.
Device manufacturing provided by the utility model is at low cost, using simplicity, can effectively mitigate tissue blood vessel damage, reduce and suffer from Person's pain, can effectively prevent blood back when carrying out seal wire operation, smaller size of lead can be also placed in by utility model device Pipe, so that the applicable scene of conduit greatly improves, clinical application is very extensive.
Detailed description of the invention
Fig. 1 is a kind of structural schematic diagram of interventional therapy conduit hemostasis device of the utility model.
Fig. 2 is a kind of sectional view of the body assembly of interventional therapy conduit hemostasis device of the utility model.
Specific embodiment
The technical solution of the utility model is described further below in conjunction with drawings and examples.
It as depicted in figs. 1 and 2, is a kind of interventional therapy conduit hemostasis device provided by the utility model, the device packet Contain: body assembly and extension component, the body assembly includes:
Shell 11;
Setting is in the intracorporal supervisor 12 of shell;
The pipe joint element 13 of supervisor front end is set, connecting conduit 1 is used for;
The rear cover 14 of supervisor rear end is set;And
The haemostatic valve 15 of rear cover inner wall is set;
The extension component includes: it is connected to the side pipe 21 of supervisor, and, the three-way cock 22 of side pipe end is set, is used In intravascular injection drug and rinse haemostatic valve.
The pipe joint element 13 selects conduit to connect knob, and conduit connection knob is internally threaded, and can pass through rotation The mode of conjunction is fixedly connected with a variety of conduits.
The haemostatic valve 15 is made of several elastics 151;In preferred embodiment, the haemostatic valve 15 is by being spaced It is embedded 3 elastics composition in rear cover inner wall side by side, capable of blocking supervisor 12, (seal wire/conduit/drug is all by the pipeline Into in conduit 1, elastic is exactly to prevent from leaking blood herein), as shown in Figure 2.3 elastics are equidistant to be embedded in rear cover, When being inserted into seal wire or conduit, it can effectively stop the leakage of blood.
The elastic column section is round or similar round.
The rear cover is sheath lid, hollow, inside sets haemostatic valve.
When in use, such as most of blood vessel interposing catheter seal wires are identical for the hemostasis device of the utility model, need to be first with life It manages salt water or heparin water or other sterile solutions and the present apparatus is rinsed by three-way cock, close threeway after inner air is discharged Switch;Physiological saline is enclosed in the present apparatus, avoids bringing air when surgical procedure into and enters Endovascular, then utilizes device The mode screwed that is threaded through of front end connects and comes into endovascular catheter tip, at this time again by back cover hole, into leading Silk carries out interventional procedure, can play the anti-return blood of the utility model and leak the effect of blood.In short, the utility model provides one While kind effectively prevent conduit blood back and leakage blood in blood vessel intervention operation, it is further provided one is used for the injection of drug Side pipe.Under the auxiliary of the utility model, utilization efficiency of the conduit in art can further improve, in special vascular conditions The number of replacement vagina vasorum can be reduced down, reduce operation risk and financial burden.
Further, all component materials of the utility model can be selected from by one in latex, silica gel, high molecular material Kind is several, and high molecular material is, for example, polypropylene, polystyrene, polyurethane, polyvinylidene alcohol, polycarbonate, nylon With Delrin (polyoxymethylene resin) etc., the combination of high molecular material that can also be two kinds or more.In a preferred embodiment, institute There is component to be all made of good biocompatibility, flexility and resists the medical silica-gel system for losing that performance is good and allows indwelling time long At.
Further, the pipe joint element of the utility model has a variety of internal diameter models available, can be led according to difference The outer diameter of pipe selects different internal diameters, and conduit described in the utility model is circular cross-section.
In one embodiment, the utility model pipe joint element 13 after flushing is connected to and has been placed in leading for blood vessel Pipe end enters seal wire by the rear cover tapping of the present apparatus, and seal wire is by haemostatic valve 15, supervisor 12, conduit 1, subsequently into Endovascular effectively avoids blood and passes through wire catheter at this time since the elastic 151 in haemostatic valve 15 is wrapped in seal wire Between gap leak out.
In one embodiment, when intervention operation in the case where seal wire and conduit have been in Endovascular, because leading Silk can not be directly open using catheter tip in conduit and carry out intravascular drug injection.It can be connected at this time in catheter tip Utility model device carries out endovascular drug injection (such as contrast agent, heparin) by side pipe, thus facilitate operation into One step carries out, and reduces the operation for exiting seal wire, reduces operation risk.
New discipline, surgical procedure rely on the consumptive materials such as various seal wires, conduit, vagina vasorum in recent years for blood vessel intervening acts, Device provided by the utility model can increase the characteristics of applicable scene of conduit, and more operation sides can be provided to medical worker Formula, clinical application are very extensive.In addition, the utility model manufacturing cost it is low, using simplicity, mitigate tissue blood vessel damage, subtract Few patient suffering can effectively prevent blood back and leakage blood when carrying out seal wire operation, can also pass through in the case where not exiting seal wire Utility model device carries out intravascular drug injection, more convenient for medical worker operates and treats.
It is discussed in detail although the content of the utility model has passed through above preferred embodiment, but it should be appreciated that on The description stated is not considered as limitations of the present invention.After those skilled in the art have read above content, for A variety of modifications and substitutions of the utility model all will be apparent.Therefore, the protection scope of the utility model should be by appended Claim limit.

Claims (7)

1. a kind of interventional therapy conduit hemostasis device, which is characterized in that the device includes: body assembly and extension component, institute The body assembly stated includes:
Shell;
It is arranged in the intracorporal supervisor of shell;
The pipe joint element for connecting conduit of supervisor front end is set;
The rear cover of supervisor rear end is set;And
The haemostatic valve of rear cover inner wall is set;
The extension component includes: it is connected to the side pipe of supervisor, and, the three-way cock of side pipe end is set.
2. interventional therapy as described in claim 1 conduit hemostasis device, which is characterized in that the pipe joint element selection Conduit connects knob.
3. interventional therapy as described in claim 1 conduit hemostasis device, which is characterized in that the haemostatic valve is by several bullets Property column constitute.
4. interventional therapy as claimed in claim 3 conduit hemostasis device, which is characterized in that the elastic interval is side by side Setting.
5. interventional therapy as claimed in claim 4 conduit hemostasis device, which is characterized in that the haemostatic valve is by embedding side by side 3 elastics for being located at rear cover inner wall are constituted.
6. interventional therapy as claimed in claim 4 conduit hemostasis device, which is characterized in that the elastic column section is circle Shape or similar round.
7. interventional therapy as described in claim 1 conduit hemostasis device, which is characterized in that the rear cover is sheath lid.
CN201820386154.2U 2018-03-21 2018-03-21 A kind of interventional therapy conduit hemostasis device Expired - Fee Related CN208436254U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201820386154.2U CN208436254U (en) 2018-03-21 2018-03-21 A kind of interventional therapy conduit hemostasis device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201820386154.2U CN208436254U (en) 2018-03-21 2018-03-21 A kind of interventional therapy conduit hemostasis device

Publications (1)

Publication Number Publication Date
CN208436254U true CN208436254U (en) 2019-01-29

Family

ID=65092861

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201820386154.2U Expired - Fee Related CN208436254U (en) 2018-03-21 2018-03-21 A kind of interventional therapy conduit hemostasis device

Country Status (1)

Country Link
CN (1) CN208436254U (en)

Similar Documents

Publication Publication Date Title
JP5026535B2 (en) System for promoting hemostasis by delivering a hemostasis promoting substance to blood vessel puncture
JP3588757B2 (en) Puncture closure
JP5269946B2 (en) Pre-jet handling system and method for delivering hemostatic material to vascular puncture site by hydraulic pressure
US20060224100A1 (en) Hemodialysis access with on-off functionality
US20060276836A1 (en) Hemostatic wire guided bandage and method of use
JP2021104346A (en) Puncturing system
JP2014521393A (en) Cleaning device and catheter kit including cleaning device
KR101671612B1 (en) Perfusion device for organ harvest surgery
US20210244371A1 (en) Coronary vein guiding system and accompanying vein guiding method and system
CN108143447A (en) A kind of dissection of aorta distal end cut plugging device
CN110292703A (en) A kind of double sacculus precisely quantify injection catheter
CN208573789U (en) Total aortic arch replacement and bracket elephant trunk technique aorta clamping device
US20060195069A1 (en) Percutaneous diagnostic and therapeutic hematoma drain
CN202654186U (en) Novel calculus-removing saccule for biliary tract
CN208436254U (en) A kind of interventional therapy conduit hemostasis device
JP6949053B2 (en) Non-implant devices and their use for temporary obstruction of blood vessels
JP2016500322A (en) Vascular closure system
US10010344B2 (en) Self-dilating catheter introducer with obturator and method of use
CN203539386U (en) Double-cavity artery sheathing canal
WO2007075515A2 (en) Devices and methods to prevent bleeding from needle puncture sites of arteriovenous grafts
CN209966651U (en) Wound fixing plaster for thrombosis experiment in animal body
CN209474728U (en) One kind taking bolt bracket and takes pin device
CN210472201U (en) Blood vessel plugging device
CN103007396B (en) Injection device used under medical endoscope
Moran et al. Totally implantable subcutaneous devices for hemodialysis access

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190129

CF01 Termination of patent right due to non-payment of annual fee